Safety and Efficacy of RD133 in Subjects With Relapsed or Refractory MSLN-Positive Solid Tumors
Abroad (travel likely)RecruitingEARLY_PHASE1
Conditions
Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Contact: Principal Investigator (Qinglei Gao, PhD, MD)
Study leads
Qinglei Gao, MD. PhD
Principal Investigator
Tongji Hospital